FR2452485A1 - Nouveaux acides et esters 4-amino-3-quinoleinecarboxyliques, utiles notamment comme agents antisecretoires et anti-ulcere - Google Patents

Nouveaux acides et esters 4-amino-3-quinoleinecarboxyliques, utiles notamment comme agents antisecretoires et anti-ulcere

Info

Publication number
FR2452485A1
FR2452485A1 FR8006516A FR8006516A FR2452485A1 FR 2452485 A1 FR2452485 A1 FR 2452485A1 FR 8006516 A FR8006516 A FR 8006516A FR 8006516 A FR8006516 A FR 8006516A FR 2452485 A1 FR2452485 A1 FR 2452485A1
Authority
FR
France
Prior art keywords
acids
alkyl
esters
amino
quinoleinecarboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8006516A
Other languages
English (en)
Other versions
FR2452485B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AH Robins Co Inc
Original Assignee
AH Robins Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AH Robins Co Inc filed Critical AH Robins Co Inc
Publication of FR2452485A1 publication Critical patent/FR2452485A1/fr
Application granted granted Critical
Publication of FR2452485B1 publication Critical patent/FR2452485B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LES MEDICAMENTS SELON L'INVENTION SONT DES ACIDES ET ESTERS 4-AMINO-3-QUINOLEINECARBOXYLIQUES DE FORMULE GENERALE: (CF DESSIN DANS BOPI) DANS LAQUELLE R REPRESENTE UN ATOME D'HALOGENE OU UN GROUPE ALKYLE INFERIEUR, PHENYLE, ALCOXY INFERIEUR, ALKYLTHIO INFERIEUR, TRIFLUOROMETHYLE, CYANO OU DIALKYLAMINO, R REPRESENTE UN GROUPE ALKYLE INFERIEUR, PHENYLE, PHENYLALKYLE INFERIEUR OU PHENYLE SUBSTITUE PAR 1 A 3 RADICAUX CHOISIS PARMI LES HALOGENES ET LES GROUPES ALKYLE INFERIEUR, ALCOXY INFERIEUR, ALKYLTHIO INFERIEUR, CYANO, HYDROXY, CARBAMOYLE, CARBOXY, ACETYLE, TRIFLUOROMETHYLE ET NITRO ET R EST UN ATOME D'HYDROGENE OU UN GROUPE ALKYLE INFERIEUR, DIMETHYLAMINOALKYLE INFERIEUR, (ALKYL INFERIEUR)ALCOXY INFERIEUR OU ALLYLE, ET LEURS SELS D'ADDITION D'ACIDES NON TOXIQUES ACCEPTABLES EN PHARMACIE. APPLICATION: COMME AGENTS ANTISECRETOIRES ET POUR LE TRAITEMENT DES ULCERES PEPTIQUES, A DES DOSES JOURNALIERES DE 100 A 1000MG CHEZ L'HUMAIN ADULTE.
FR8006516A 1979-03-26 1980-03-24 Nouveaux acides et esters 4-amino-3-quinoleinecarboxyliques, utiles notamment comme agents antisecretoires et anti-ulcere Expired FR2452485B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2398179A 1979-03-26 1979-03-26
US06/127,153 US4343804A (en) 1979-03-26 1980-03-04 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds

Publications (2)

Publication Number Publication Date
FR2452485A1 true FR2452485A1 (fr) 1980-10-24
FR2452485B1 FR2452485B1 (fr) 1986-09-12

Family

ID=26697875

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8006516A Expired FR2452485B1 (fr) 1979-03-26 1980-03-24 Nouveaux acides et esters 4-amino-3-quinoleinecarboxyliques, utiles notamment comme agents antisecretoires et anti-ulcere

Country Status (31)

Country Link
US (1) US4343804A (fr)
JP (1) JPH02117663A (fr)
AR (1) AR230268A1 (fr)
AT (1) AT372373B (fr)
AU (1) AU528388B2 (fr)
BR (1) BR8001779A (fr)
CA (1) CA1147338A (fr)
CH (1) CH644105A5 (fr)
DE (1) DE3011490A1 (fr)
DK (1) DK156056C (fr)
EG (1) EG15009A (fr)
ES (1) ES8103048A1 (fr)
FI (1) FI77452C (fr)
FR (1) FR2452485B1 (fr)
GB (1) GB2047244B (fr)
GR (1) GR68006B (fr)
HK (1) HK67983A (fr)
IE (1) IE49577B1 (fr)
IL (1) IL59628A (fr)
IN (1) IN151446B (fr)
IT (1) IT1133079B (fr)
MX (1) MX6264E (fr)
NL (1) NL8001752A (fr)
NO (1) NO153927C (fr)
NZ (1) NZ193252A (fr)
PH (1) PH16416A (fr)
PL (1) PL125030B1 (fr)
PT (1) PT71008B (fr)
SE (1) SE435837B (fr)
SG (1) SG33683G (fr)
YU (1) YU41702B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610981D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Quinoline amides
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5432182A (en) * 1989-02-23 1995-07-11 Smithkline Beecham Intercredit B.V. Compounds substituted quinoline derivatives
CA2011086A1 (fr) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, leur utilisation et medicaments les contenant
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
US5362743A (en) * 1993-03-09 1994-11-08 Pfizer Inc. Aminoquinoline derivatives
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
EP0720601B1 (fr) * 1993-08-10 2000-10-25 James Black Foundation Limited Ligands de recepteur de cck et de gastrine
US5650415A (en) * 1995-06-07 1997-07-22 Sugen, Inc. Quinoline compounds
KR0169813B1 (ko) * 1995-07-12 1999-01-15 김종인 4-아미노-3-아실나프티리딘 유도체
US5760041A (en) * 1996-02-05 1998-06-02 American Cyanamid Company 4-aminoquinazoline EGFR Inhibitors
US6875769B2 (en) * 1996-05-23 2005-04-05 Pfizer Inc. Substituted6,6-hetero-bicyclicderivatives
US5929080A (en) * 1997-05-06 1999-07-27 American Cyanamid Company Method of treating polycystic kidney disease
US6251912B1 (en) 1997-08-01 2001-06-26 American Cyanamid Company Substituted quinazoline derivatives
US6323209B1 (en) 1997-11-06 2001-11-27 American Cyanamid Company Method of treating or inhibiting colonic polyps
ES2457396T3 (es) 1998-09-29 2014-04-25 Wyeth Holdings Llc 3-Cianoquinolinas sustituidas como inhibidores de las proteínas tirosina quinasas
HUP0203973A3 (en) * 1999-12-28 2004-07-28 Eisai Co Ltd Heterocyclic compounds having sulfonamide groups, pharmaceutical compositions containing them and their use
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6576644B2 (en) * 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
GEP20084540B (en) 2003-01-14 2008-11-25 Arena Pharm Inc 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
TWI335328B (en) * 2003-07-14 2011-01-01 Arena Pharm Inc Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related hereto
WO2006097456A1 (fr) * 2005-03-16 2006-09-21 Nycomed Gmbh Forme posologique a gout masque
WO2011022216A1 (fr) * 2009-08-17 2011-02-24 High Point Pharmaceuticals, Llc Dérivés de pyridine substitués, compositions pharmaceutiques et procédés d'utilisation pour traiter le stress oxydatif
CN103221391B (zh) 2010-01-27 2018-07-06 艾尼纳制药公司 (R)-2-(7-(4-环戊基-3-(三氟甲基)苄基氧基)-1,2,3,4-四氢环戊二烯并[b]吲哚-3-基)乙酸及其盐的制备方法
CA2812061A1 (fr) 2010-09-22 2012-03-29 Arena Pharmaceuticals, Inc. Modulateurs du recepteur gpr119 et traitement des troubles qui lui sont lies
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
KR102603199B1 (ko) 2015-06-22 2023-11-16 아레나 파마슈티칼스, 인크. Ｓ1ｐ1 수용체-관련 장애에서의 사용을 위한 (ｒ)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[ｂ]인돌-3-일)아세트산 (화합물 1)의 결정성 ｌ-아르기닌 염
UA126119C2 (uk) * 2016-11-11 2022-08-17 Баєр Енімал Хелс Гмбх Протигельмінтні похідні хінолін-3-карбоксаміду
MX2019009841A (es) 2017-02-16 2020-01-30 Arena Pharm Inc Compuestos y metodos para el tratamiento de la colangitis biliar primaria.
US20210177827A1 (en) * 2017-10-25 2021-06-17 Children`S Medical Center Corporation Papd5 inhibitors and methods of use thereof
SG11202010024UA (en) 2018-05-09 2020-11-27 Bayer Animal Health Gmbh New quinoline derivatives

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4838712A (fr) * 1971-09-18 1973-06-07

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CA1958 *
CA1962 *
CA1970 *
EXBK/46 *
EXBK/51 *
EXBK/69 *

Also Published As

Publication number Publication date
CA1147338A (fr) 1983-05-31
NO153927C (no) 1986-06-18
US4343804A (en) 1982-08-10
ES489887A0 (es) 1981-02-16
IT1133079B (it) 1986-07-09
FR2452485B1 (fr) 1986-09-12
JPH02117663A (ja) 1990-05-02
DE3011490A1 (de) 1981-03-12
GB2047244B (en) 1983-02-23
IL59628A0 (en) 1980-06-30
FI77452B (fi) 1988-11-30
GR68006B (fr) 1981-10-26
PL125030B1 (en) 1983-03-31
CH644105A5 (fr) 1984-07-13
MX6264E (es) 1985-02-19
SE8002292L (sv) 1980-09-27
PL222993A1 (fr) 1981-01-30
DK156056B (da) 1989-06-19
PT71008A (en) 1980-04-01
PH16416A (en) 1983-09-29
HK67983A (en) 1983-12-23
IL59628A (en) 1983-06-15
FI800910A (fi) 1980-09-27
IE800605L (en) 1980-09-26
IT8067465A0 (it) 1980-03-26
YU84480A (en) 1983-10-31
EG15009A (en) 1985-03-31
YU41702B (en) 1987-12-31
FI77452C (fi) 1989-03-10
NL8001752A (nl) 1980-09-30
BR8001779A (pt) 1980-11-18
PT71008B (en) 1981-06-25
NO153927B (no) 1986-03-10
DE3011490C2 (fr) 1988-12-22
NZ193252A (en) 1984-04-27
IE49577B1 (en) 1985-10-30
NO800858L (no) 1980-09-29
SG33683G (en) 1985-03-29
ES8103048A1 (es) 1981-02-16
GB2047244A (en) 1980-11-26
IN151446B (fr) 1983-04-23
AU528388B2 (en) 1983-04-28
AT372373B (de) 1983-09-26
AR230268A1 (es) 1984-03-01
AU5684880A (en) 1980-10-02
DK128380A (da) 1980-09-27
ATA156480A (de) 1983-02-15
SE435837B (sv) 1984-10-22
DK156056C (da) 1989-11-06

Similar Documents

Publication Publication Date Title
FR2452485A1 (fr) Nouveaux acides et esters 4-amino-3-quinoleinecarboxyliques, utiles notamment comme agents antisecretoires et anti-ulcere
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
FR2360587A1 (fr) Nouveaux derives d'amino-alcoyl-furannes utiles comme medicaments
NO152130C (no) Analogifremgangsmaate for fremstilling av bronchospasmolytisk virksomme forbindelser
NO843836L (no) Terapeutisk aktive sulfamatderivater
FR2371437A1 (fr) Nouveaux derives de pipepidine ou de morpholine utiles comme medicaments et comme fongicides
FR2422634A1 (fr) Isosteres de type 9-desoxy-9a-methylene de pgi2, utiles comme medicaments, et leur procede de preparation
FR2456733A1 (fr) Nouveaux acides 2-(mercapto-1-oxo(alkyl inferieur))-1,2,3,4-tetrahydroisoquinoleine-3-carboxyliques, utiles notamment comme inhibiteurs de l'enzyme de conversion de l'angiotensine i
ES8707947A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos.
FR2391723A1 (fr) Composition therapeutique a base de cetone aliphatique pour le traitement des ulceres peptiques
FR2360561A1 (fr) Nouveaux dipeptides utiles comme inhibiteurs de l'elastase
FR2361346A1 (fr) Dipeptides utiles comme medicaments
BR8806558A (pt) Processos para preparacao de compostos
ATE62908T1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
ES2037077T3 (es) Metodo para preparar quinona-amidas.
ATE24911T1 (de) Pyrido(3',4':4,5)furo(3,2-g)coumarine oder pyrido(3,4-h)psoralene, herstellung, verwendung in der kosmetologie und als arzneimittel und diese enthaltende zubereitungen.
ATE110568T1 (de) Pharmazeutisches präparat zur behandlung des katarakts.
FR2355011A1 (fr) 2-imino-3-aminothiazolidines utiles comme medicaments
ES8300096A1 (es) "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
FR2359154A1 (fr) Derives peptidiques utiles comme medicaments et procede pour leur preparation
ES552782A0 (es) Un procedimiento para preparar un compuesto de n-fenil-trans-4-guanidincometilciclohexanocarboxamida.
FR2377382A1 (fr) Nouveaux phenylazacycloalcanes utiles comme medicaments
FR2388810A1 (fr) 3-(1-piperazinyl)-1,2,4-benzotriazines et n-oxydes utiles comme medicaments
WO1987003287A3 (fr) PROCEDE POUR LA PREPARATION DE COMPOSES alpha-HYDROXY CARBONYLES
FR2420975A1 (fr) Medicaments anticomplementaires en partie antinephretiques, de type soyasapogenol b et leur procede de preparation

Legal Events

Date Code Title Description
ST Notification of lapse